WASHINGTON (Reuters) - The sweeping tax overhaul that passed the U.S. Senate on Saturday contains the Republicans' biggest blow yet to former President Barack Obama's healthcare law, repealing the requirement that all Americans obtain health insurance. [Source]
Dec 14 (Reuters) - CSX Corp said on Thursday its Chief Executive Officer Hunter Harrison was taking medical leave, an announcement that comes amid of a controversial turnaround plan at the No. 3 U.S. railroad that has drawn customer criticism and scrutiny from regulators.
(Reuters Health) - Social media groups that bring together patients, family, friends and healthcare providers can improve patientsâ€™ outlook and reduce their anxiety and depression, a recent U.S. study suggests.
(Reuters Health) - The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.
LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.
FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators' concerns about side effects having frustrated its ambitions almost seven years ago.
(Reuters Health) - Brain cells - neurons - develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.
NEW DELHI (Reuters) - Indian Prime Minister Narendra Modi's ruling group will sweep an election in his home state of Gujarat, surveys showed on Thursday, shaking off the most serious challenge yet from a combined opposition.
WASHINGTON (Reuters) - Alabama Democrat Doug Jones, who won a bitter fight for a U.S. Senate seat this week, called on his Republican opponent to concede the race and help heal the Southern state after a deeply divisive contest.
NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.
MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.
MEXICO CITY (Reuters) - Mexican Senate committees on Wednesday approved a controversial security bill that human rights groups say risks granting excessive power to the armed forces in their already checkered role in combating organized crime in the country.
WASHINGTON (Reuters) - U.S. President Donald Trump's eldest son met with the U.S. Senate Intelligence Committee on Wednesday as part of the panel's investigation into Russia, the 2016 U.S. election and whether his father's election campaign colluded with Moscow.
CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.
CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasichâ€™s desk.
WASHINGTON (Reuters) - Two of President Donald Trump's judicial nominees will not be confirmed by the Republican-controlled U.S. Senate following criticism over controversial statements they made, a White House official said.
TEL AVIV (Reuters) - Reports that Teva Pharmaceutical Industries is planning a restructuring involving mass layoffs in Israel sparked calls on Wednesday for a half-day general strike to be held in protest.
BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.
DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.
(Reuters) - Minnesota's Democratic Lieutenant Governor Tina Smith was appointed as U.S. senator by the state's governor on Wednesday to replace Al Franken, who resigned after being accused of sexual harassment.
(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.
WASHINGTON (Reuters) - Congressional Republicans have reached a deal on final tax legislation, the top Senate Republican tax writer said on Wednesday, with President Donald Trump saying minutes later he would back a corporate tax rate of 21 percent.
NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.
WASHINGTON (Reuters) - U.S. President Donald Trump's eldest son met with the U.S. Senate Intelligence Committee on Wednesday as part of the panel's investigation into Russia, the 2016 U.S. election and whether his father's election campaign colluded with Moscow.
NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run HealthCare.gov website, picking up the pace ahead of the Dec. 15 deadline.
WASHINGTON (Reuters) - The top Democrat in the U.S. Senate said bipartisan negotiations to protect undocumented people who immigrated to the United States as children were making very good progress, and that he hoped a bill could clear Congress by year-end.
NEW YORK (Reuters) - More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9, the U.S. government reported on Wednesday, indicating a pick up in the pace of enrollment as the Dec. 15 deadline nears.
STRASBOURG (Reuters) - Doner kebab vendors across Europe won a victory in the European Parliament on Wednesday when European Union lawmakers failed to outlaw additives regularly used to preserve taste and moisture.
TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said.
LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday.
(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.
MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday.
PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.
TOKYO (Reuters) - U.S. stock futures, Treasury yields and the dollar dipped on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares gained as crude oil futures took back some lost ground.
TOKYO, Dec 13 (Reuters) - U.S. stock futures, Treasury yields and the dollar dipped on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares gained as crude oil futures took back some lost ground.
WASHINGTON (Reuters) - In backing Roy Moore in Alabama's U.S. Senate race even though the candidate faced allegations of sexual misconduct with teenage girls, President Donald Trump made a risky bet - and lost big.
TOKYO (Reuters) - U.S. stock futures, Treasury yields and the dollar fell on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares edged up as crude oil futures took back lost ground.
BIRMINGHAM, Ala. (Reuters) - Democrat Doug Jones won a bitter fight for a U.S. Senate seat in deeply conservative Alabama on Tuesday, U.S. media projected, dealing a political blow to President Donald Trump in a race marked by accusations of sexual misconduct against Republican candidate Roy Moore.
MONTGOMERY, Ala. (Reuters) - A bitter U.S. Senate race in Alabama with high stakes for President Donald Trump was too close to call on Tuesday, with Republican Roy Moore leading despite allegations against the candidate of sexual misconduct toward teenagers.
CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.
MONTGOMERY, Ala. (Reuters) - Polls closed on Tuesday in a bitter U.S. Senate race in Alabama with high stakes for President Donald Trump, who has endorsed fellow Republican Roy Moore despite allegations against the candidate of sexual misconduct toward teenagers.
OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control.
WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans.
(Reuters Health) - Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. â€“ a population at significant risk of contracting the human immunodeficiency virus (HIV) â€“ reported ever using the pill that protects them from the virus, in a recently published study.
(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts.
WASHINGTON (Reuters) - Senate Majority Leader Mitch McConnell said on Monday he was confident the U.S. Congress would be able to reach an agreement to fund the government when the current spending bill ends on Dec. 22 and that there would be no forced government shutdown.
BRASÃLIA/SAO PAULO (Reuters) - Brazilian senators passed on Tuesday a bill proposing sharp increases in the use of biofuels such as ethanol and biodiesel in the country in coming years, as a way to help cut carbon emissions.
LONDON, Dec 12 (Reuters) - The British government on Tuesday began a long-delayed hunt for a new head of the Serious Fraud Office (SFO) after announcing plans to create a new national economic crime centre with the power to instruct the anti-fraud agency to investigate cases.
WASHINGTON (Reuters) - A bipartisan push in the Senate to protect undocumented people who immigrated to the United States as children is gaining momentum as lawmakers try to wrap up negotiations this month, Republican Senator Jeff Flake said on Tuesday.
PARIS (Reuters) - California and Washington state joined five nations on the Pacific coast of the Americas on Tuesday to agree to step up the use of a price on carbon dioxide emissions as a central economic policy to slow climate change.
LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday.
LONDON (Reuters) - The number of salmonella food poisoning cases in the European Union has risen by 3 percent since 2014 in a "worrying" reversal of a decade-long declining trend, EU health and food safety officials said on Tuesday.
In today's Alabama US Senate election, Democrat Doug Jones isn't running just against Republican Roy Moore. Jones is also running against the most powerful trend shaping modern elections for the US Senate.
GENEVA (Reuters) - Cholera has killed 15 people and made 547 sick in Zambia's capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization.
(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.
(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.
(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.
(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.
Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capitalâ€™s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.
LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.
MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.
PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.
(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.
(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.
MEXICO CITY (Reuters) - Mexican President Enrique Pena Nieto on Friday asked Senate lawmakers to include civil society's views in their discussion of a divisive bill that critics say would give the military greater powers and deepen its role in the country's drug war.
LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.
(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.
(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.
KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.
WARSAW (Reuters) - Poland's lower house of parliament approved changes to the country's Supreme Court on Friday, a key part of a planned judiciary overhaul criticized by the European Union as contrary to democratic standards.
(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.
SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.
MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.
ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.
(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.
(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.
CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.
WASHINGTON (Reuters) - The Senate on Thursday confirmed the Environmental Protection Agency's third high-level official after Administrator Scott Pruitt, approving Susan Bodine to become the agency's top enforcement official.
As the calendar nears 2018, the battle for control of the Senate is shifting in all sorts of unexpected ways -- changes driven primarily by bad behavior but also a national political environment heavily colored by President Donald Trump's widespread unpopularity.
Former Fox News anchor Gretchen Carlson declined Thursday to rule out a run for the US Senate, telling CNN's Poppy Harlow and John Berman that she's been asked to run in her home state of Connecticut.
(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.
JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.
LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.
(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.
(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.
JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.
Doug Jones' bid to become the first Democrat to win a Senate race in Alabama in 25 years could hinge on whether he convinces African-Americans -- the party's only reliable voting bloc in the deep-red state -- to turn out in huge numbers.
(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.
WASHINGTON (Reuters) - Democrat Al Franken will resign from the U.S. Senate on Thursday, Minnesota Public Radio reported, after more than half of his Senate Democratic colleagues urged him to do so in light of sexual misconduct accusations.
(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.
WASHINGTON (Reuters) - A top U.S. Senate Republican voiced optimism that congressional negotiators will reach a deal on a sweeping tax overhaul ahead of a Dec. 22 deadline, as senators voted on Wednesday to begin talks with the House to bridge differences between their rival bills.
WASHINGTON (Reuters) - Half of Democrats in the U.S. Senate on Wednesday called for fellow party member Senator Al Franken of Minnesota to resign after new allegations of sexual misconduct against him.
WASHINGTON (Reuters) - A top U.S. Senate Republican voiced optimism that congressional negotiators will reach a deal on a sweeping tax overhaul ahead of a Dec. 22 deadline, as senators prepared to vote on Wednesday to authorize talks with the House to bridge differences between their rival bills.
(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.
WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.
WASHINGTON (Reuters) - U.S. Senate Majority Leader Mitch McConnell said the Senate will vote later on Wednesday on whether to send its tax legislation to a conference to hammer out differences with the U.S. House of Representatives' version of the plan.
BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.
MEXICO CITY (Reuters) - Mexican soldiers arbitrarily executed two people after an illegal raid last year, a national rights body said on Tuesday, releasing its findings as protests disrupted a debate in the Senate over a contentious bill to give the military more powers.
WASHINGTON (Reuters) - Republicans in U.S. House of Representatives began staking out their positions on final tax legislation on Tuesday, days ahead of talks with the Senate to shape the tax package lawmakers hope to send to President Donald Trump by year end.
HOUSTON, Dec 5 (Reuters) - Independent U.S. refiner Andeavor said on Tuesday it will not abandon a push to build a Pacific Coast rail-to-marine terminal despite a Washington state panel's recommendation against the project.
LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.
(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.
WASHINGTON (Reuters) - The U.S. Senate on Tuesday confirmed President Donald Trump's choice to lead the Department of Homeland Security (DHS), a post that opened after John Kelly became Trump's chief of staff earlier this year.
SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.
ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.
(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who donâ€™t consume these foods, a recent experiment suggests.
(Reuters) - Even as the U.S. Senate moves to allow oil drilling in Alaska's Arctic National Wildlife Refuge (ANWR), the real action is 150 miles (241 km) west, where industry proponents hope a coming sale of 10 million acres of land will revitalize the state's sagging crude production.
(Reuters) - The Republican Party will resume funding the U.S. Senate campaign of Roy Moore after President Donald Trump endorsed the Alabama Republican, who is accused of sexual misconduct against teenage girls.
(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.
(Reuters) - The Republican Party will resume funding the embattled U.S. Senate campaign of Roy Moore after President Donald Trump endorsed the Alabama Republican, who is accused of sexual misconduct against teenage girls.
(Reuters) - Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a midstage trial.
MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.